'Immediately Practice-Changing' Trial in Small Cell Lung Cancer

(MedPage Today) — CHICAGO — The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment of small cell lung cancer (SCLC), a practice-changing phase III trial showed.
In patients whose…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115891

Author :

Publish date : 2025-06-03 21:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

‘Immediately Practice-Changing’ Trial in Small Cell Lung Cancer

Infant RSV shot may be more effective than vaccines during pregnancy

Myeloma Trial Results Spark Talk of ‘Potential Cure’

Related Posts

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

Human trials point the way towards an mRNA vaccine against HIV

Categories

Archives